Some of us have spent years making life work through systems. Lists. Alarms. Last minute deadlines. Starting everything late and somehow finishing on time.
Then perimenopause arrives and the systems begin to fall apart. We read the same email three times. We walk into a room and forget why. We know what needs to happen, yet getting started can feel impossible. Small tasks sit there all day. Our patience gets thinner. The mental load gets heavier.
It is easy to call all of it brain fog. Sometimes it is. Sometimes ADHD has been there for years, and the menopause transition makes it harder to manage. Telling those two apart starts with understanding what each one looks like.
The overlap deserves a closer look
Perimenopause can affect sleep, mood, attention, memory, and executive function. ADHD can affect many of those same areas. When both are present, the overlap can be hard to untangle. A 2025 cohort study found that women with higher ADHD traits also reported more menopausal difficulties, although that association cannot establish that one causes the other.
ADHD is a neurodevelopmental condition. A proper assessment looks for patterns that began earlier in life, appeared in more than one setting, and caused meaningful difficulty at school, work, home, or in relationships. A woman can reach midlife without a diagnosis because she learned how to compensate. Intelligence, urgency, anxiety, perfectionism, and detailed systems can hold a great deal together for a long time.
Perimenopause can make those systems less dependable. It can also bring cognitive changes that deserve menopause focused care on their own. Both can be part of the same picture. The question is not whether we should choose one explanation. The question is what has been present for years, what has changed during perimenopause, and what support fits the full picture.
Why hormones may matter
ADHD involves differences in brain systems that help us direct attention, plan, organize, begin tasks, regulate impulses, and manage emotion. Dopamine and norepinephrine help these systems work. They help the prefrontal cortex decide what needs our attention and stay with it long enough to get something done.
Estrogen interacts with dopamine signaling. Research across puberty, the menstrual cycle, pregnancy, and postpartum suggests that shifts in sex hormones may be associated with changes in ADHD symptoms for some women. The current research is limited. A 2025 systematic review identified only 11 studies, mainly focused on puberty and the menstrual cycle, and found no empirical studies that directly investigated ADHD during menopause.
That research gap matters. We can recognize a clinical pattern without overstating what the evidence has proven.
For women who have always relied on pressure, novelty, intense interest, or elaborate systems to get through the day, a sudden loss of focus during perimenopause deserves a more complete conversation. It may reflect menopausal cognitive symptoms. It may reflect ADHD that has become harder to manage. It may be both.
Support starts with the right evaluation
An ADHD diagnosis should come from a qualified clinician with training in adult ADHD. The assessment should cover childhood patterns, current symptoms, impact across settings, sleep, mood, medications, medical conditions, and the changes happening through perimenopause. Diagnosis should never rest on a questionnaire alone.
Treatment can include medication, structured psychological support, behavioral tools, sleep support, movement, and changes to the environment. For adults who receive an ADHD diagnosis and whose symptoms continue to create significant impairment after environmental changes, NICE recommends discussing medication options with an appropriately trained clinician. That recommendation (NICE guideline NG87, recommendation 1.7.11) applies to first-line pharmacological treatment for adults with diagnosed ADHD. It does not apply to perimenopausal concentration changes in the absence of an ADHD diagnosis, and it does not mean stimulant medication treats menopause-related cognitive symptoms. The evidence on ADHD medication specifically for perimenopausal women is still developing. A thoughtful plan can hold both the hormonal context and the attentional pattern at the same time.
Reduce the daily friction
Phone notifications pull us into constant task switching. A visually busy workspace adds more information for the brain to sort. An unstructured day leaves every decision open until we run out of energy.
A few changes can lower the daily load:
- Put the phone in another room during focused work
- Write the next physical action for each important task
- Use short timed work blocks and plan the break before starting
- Create a simple transition between meetings, focused work, meals, and home life
- Protect sleep as a core part of cognitive function
Omega 3 fatty acids may help some people as an adjunct, although they are not a replacement for assessment or first line ADHD treatment. The effects seen across trials are generally small and mixed, and much of the research comes from children and adolescents. The goal is to build conditions that make follow through less costly.
Go deeper
The Overlap Decade Series goes deeper into the systems that shape the menopause transition across 13 modules. We cover the brain, metabolic health, hormones, sleep, and the questions that help us make sense of what is changing. It is built for women who want the science and practical context without having to piece it together alone.
Explore The Overlap Decade Series (https://saujanyavemuri.com/overlap-decade-series/)
This article is educational and does not replace individual medical evaluation, diagnosis, or treatment.
Sources
- Young S, Adamo N, Asgeirsdottir BB, et al. Females with ADHD: an expert consensus statement taking a lifespan approach providing guidance for the identification and treatment of attention-deficit/hyperactivity disorder in girls and women. BMC Psychiatry. 2020;20(1):404. doi:10.1186/s12888-020-02707-9.
- Osianlis E, Thomas EHX, Jenkins LM, Gurvich C. ADHD and sex hormones in females: a systematic review. J Atten Disord. 2025;29(9):706-723. doi:10.1177/10870547251332319.
- Jakobsdottir Smari U, Valdimarsdottir UA, Wynchank D, et al. Perimenopausal symptoms in women with and without ADHD: a population based cohort study. Eur Psychiatry. 2025;68(1):e133. doi:10.1192/j.eurpsy.2025.10101.
- Chang JPC, Su KP, Mondelli V, Pariante CM. Omega-3 polyunsaturated fatty acids in youths with attention deficit hyperactivity disorder: a systematic review and meta-analysis of clinical trials and biological studies. Neuropsychopharmacology. 2018;43(3):534-545. doi:10.1038/npp.2017.160.
- Bloch MH, Qawasmi A. Omega-3 fatty acid supplementation for the treatment of children with attention-deficit/hyperactivity disorder symptomatology: systematic review and meta-analysis. J Am Acad Child Adolesc Psychiatry. 2011;50(10):991-1000. doi:10.1016/j.jaac.2011.06.008.
- National Institute for Health and Care Excellence. Attention deficit hyperactivity disorder: diagnosis and management. NICE guideline NG87. 2018. https://www.nice.org.uk/guidance/ng87 (recommendation 1.7.11: first-line pharmacological treatment for adults with diagnosed ADHD).
Clinical note: This article provides general education, not individualized medical advice. Discuss symptoms, treatments, hormones, medications, supplements, and significant health decisions with a qualified clinician.
Work With Saujanya
Explore menopause and metabolic-health consulting, speaking, and strategic support for individuals and organizations: Services (https://saujanyavemuri.com/services)
Additional Resources
- The Overlap Decade Series (https://saujanyavemuri.com/overlap-decade-series/)
- Discover Your Health Archetype (https://saujanyavemuri.com/overlap-decade-series/health-archetype/?utm_source=sales-page&utm_medium=escape-hatch&utm_campaign=soft-launch)